 Bloomberg | Ranbaxy Falls Most Since March on Settlement Costs: Mumbai Mover BusinessWeek 27 (Bloomberg) -- Ranbaxy Laboratories Ltd., India's biggest drugmaker, slumped the most in ten months in Mumbai trading because of costs of a proposed settlement with US authorities over manufacturing violations. Ranbaxy declined 6.5 percent to 443.90 ... Ranbaxy scrip tanks 7% on 'harsh settlement' in US Ranbaxy Falls Most Since March on Proposed Settlement Costs: Mumbai Mover Ranbaxy shares dive on US settlement plan |
© 2012 Settlements and Annuity News. All Rights Reserved.
Powered by Wordpress. Designed by 